Dinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Children's Oncology Group
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Children's Oncology Group
NYU Langone Health
Roswell Park Cancer Institute
Columbia University
Children's Oncology Group